Dicyclohexylcarbodiimide → (1R,4R)-3-Benzoyl-4-[(R)-alpha-methyl-p-hydroxybenzylcarbamoyl]-1-oxothiazolidine

온도

5 °C

9.47 g (69.11 mmole) of (R)-α-methyl-p-hydroxybenzylamine (prepared as described in Preparation 13), 10.58 g (69.11 mmole) of N-hydroxybenzotriazole monohydrate and 14.26 g (69.11 mmole) of dicyclohexylcarbodiimide were added in that order to a solution of 17.50 g (69.11 mmole) of (1R,4R)-3-benzoyl-1-oxo-thiazolidine-4-carboxylic acid (prepared as described in Preparation 10) in 100 ml of dimethylformamide cooled at 5° C., and the mixture was stirred at a temperature between 3° and 6° C. for 30 minutes and then at room temperature for a further 4 hours. At the end of this time, the reaction mixture was filtered and the insolubles were washed with 100 ml of hot dimethylformamide. The filtrate and the washings were combined and concentrated by evaporation under reduced pressure to leave crystals. These crystals were recrystallized from methanol to give 19.21 g (74.6%) of the title compound in the form of colorless needles melting at 233°-234° C.

1. waitat room temperature for a further 4 hours
2. filtrationAt the end of this time, the reaction mixture was filtered
3. washthe insolubles were washed with 100 ml of hot dimethylformamide
4. concentrationconcentrated by evaporation under reduced pressure
5. customto leave crystals
6. customThese crystals were recrystallized from methanol

ORD 기록

ord-c378ca8c01614734af1cb78e95f7eefd

출처 데이터셋

uspto-grants-1990_02

DOI

10.6084/m9.figshare.5104873.v1

특허 번호

US04904680